Group 1 - Invea Therapeutics, a clinical-stage biotech company developing oral small molecule drugs for inflammatory diseases, withdrew its initial public offering (IPO) plan due to market conditions [1] - The company had previously filed a prospectus to issue 3.2 million shares at a price range of $10 to $12 per share, aiming to raise $35 million [1] - Founded in 2021 and headquartered in Guilford, Connecticut, Invea Therapeutics planned to list on NASDAQ under the ticker symbol INAI [1] Group 2 - ThinkEquity was set to be the exclusive book-running manager for the IPO transaction [1]

智通财经APP获悉，开发炎症性疾病口服小分子药物的临床阶段生物科技公司Invea Therapeutics(INAI.US)于上周五以市场状况为由，撤回了其美股首次公开募股计划。该公司此前提交的 招股书显示，拟以每股10至12美元的价格发行320万股，募资3500万美元。 这家总部位于康涅狄格州吉尔福德的公司成立于2021年，原计划在纳斯达克上市，股票代码为INAI。 ThinkEquity原定为该交易的独家账簿管理人。 ...

As filed with the Securities and Exchange Commission on January 27, 2026. Registration Statement No. 333-292131 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ Delaware 2834 87-3198325 (State or other jurisdiction of in ...

As filed with the Securities and Exchange Commission on January 23, 2026. Registration Statement No. 333-292131 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ Delaware 2834 87-3198325 (State or other jurisdiction of in ...

As filed with the Securities and Exchange Commission on January 6, 2026. Registration Statement No. 333-292131 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ Delaware 2834 87-3198325 (State or other jurisdiction of inc ...

Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________________________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 __________________________________ Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) __________________________________ (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 87-3198325 (I.R.S. Emplo ...

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 26, 2024. Registration Statement No. 333-275109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 87-3198325 (I.R.S. Employer Identification Number) (Primary Standard Industrial Classification Code Number) 2614 Boston Post Road, Suite ...

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 12, 2024. Registration Statement No. 333-275109 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial 87-3198325 (I.R.S. Employer Identificati ...

TABLE OF CONTENTS As filed with the Securities and Exchange Commission confidentially on October 20, 2023. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Invea Therapeutics, Inc. (Exact name of registrant as specified in its charter) 2834 (Primary Standard Industrial Classification Code Number) 87-3198325 (I.R.S. Employer 2614 Boston Post Road, Suite 33AR Guilford, Connecticut 06437 (203 ...